Here is a description of your company. Proin ex id consectetur lobortis. Aliquam, velit vel faucibus dapibus, augue justo ullamcorper turpis, nec convallis metus nunc vel turpis.
All in Genetics
Twist Exome 2.0: A new and powerful exome panel with best-in-class performance for translational research and more
With flu season approaching, labs are contemplating new, more efficient ways to differentiate between respiratory viruses. Multiplex, PCR-based tests could save both labs and patients significant heartache.
In the milieu of rushing blood, plasma, and cells, small wayward bits of DNA are easy to overlook. But stored within these scraps of genetic material, known as cell-free DNA (cfDNA), is information offering the earliest glimpses of cancer development. Being able to detect and understand these signals could dramatically improve our ability to detect and treat cancer before the disease has developed.
98% of the human genome consists of non-protein-coding DNA, much of which has unknown functions. Nonetheless, noncoding DNA houses important genetic elements that can alter gene expression levels through genetic and epigenetic means, such as enhancers, silencers, promoters, and other so-called regulatory elements. The average protein-coding gene is governed by multiple non-coding regulatory elements whose activity can vary in a context-dependent manner, making it exceedingly difficult to both identify these elements and link them to the transcriptional activity of specific genes. Without a detailed understanding of these regulatory elements, potentially clinically relevant information coded within the growing influx of genetic data will remain undiscovered. To help convert data into knowledge, researchers are turning to Massively Parallel Reporter Assays (MPRAs).
Advances in population-scale sequencing are leading researchers to new and valuable data sources, and revealing early signals of disease to study participants.
Renown Institute for Health Innovation partnered with Helix to help carry out a large-scale genetic screening and research initiative.
When Watson and Crick’s paper was published in 1953, they knew very little about DNA. We’ve come a long way since then. In honor of DNA Day—the holiday commemorating their seminal paper—we thought we’d reflect on just how much we’ve learned over these past six decades.
It’s rare for a gene to be elevated into public discussion, and even rarer for a gene’s importance to be highlighted by celebrities and world leaders. While each gene on the ACMG 59 is incredibly important, no other gene has captured the public eye quite like the BRCA genes.
Cancer is a scary topic, in part because people usually only hear about it after they (or someone they know) has developed it. But that doesn’t have to be the case.
What’s the difference between early-onset, and late-onset Alzheimer’s disease? Here, we explore the history of Alzheimer’s and discuss the differences between the two forms.
It’s been nearly 15 years since the completion of the Human Genome Project. In the years that have passed, we’ve seen a windfall of scientific discovery and innovation. We’ve highlighted a few exciting trends in DNA, ranging from large-scale data sets to DNA-based storage.
Exactly what causes Alzheimer's is still unknown, but many signs point to changes in the APOE gene. While Alzheimer’s cannot be cured, it may be delayed by making proactive lifestyle choices. Find out how the APOE gene may factor into a person's risks of developing Alzheimer's in this week's Weekly Gene.
You’ve probably heard of Type 1 and Type 2 diabetes. But did you know there are several other types as well?
In 1970, Dr. Susumu Ohno suggested that repetition within the DNA sequence could have dramatic effects on our traits. Now, more than 50 years later, we know that Dr. Ohno was right—repetition in DNA does affect our traits, and there’s a lot of it.
This week, the world learned about a different kind of zombie—one that’s not made of bones or flesh. This kind of zombie is made of DNA, and it may be playing an important role in the evolution of elephants. It could also be helping humans grow large brains.
What do viruses, DNA, and coal have in common? They were all studied by Dr. Rosalind Franklin.
Dr. Chase had a relatively short career in science, but it was an extremely productive one.
Dr. Stevens was coming into science at a time when there was very little known about heredity.
Looking at the list of common risk factors, you can easily see how a modern lifestyle can increase a person’s risk of having heart disease. On average, people eat more, smoke more, and walk less than our ancestors. But if heart disease was simply a product of our modern lifestyle, why do so many mummies have it?
Imagine for a moment that 20 people were sent from earth to establish a human colony on Mars. From these people, a new society would have to be formed.
